See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2012_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 355,145 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,946 |
| 3 | remainder_Assets | 11,503 |
| 4 | LiabilitiesCurrent | 810,659 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,456,028 |
| 9 | ResearchAndDevelopmentExpense | 5,067,085 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,516,061 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 383,594 |
| 1 | Liabilities | 810,659 |
| 2 | Expenses | 7,523,113 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -427,065 |
| 5 | NetIncome | -6,007,052 |
| 6 | ComprehensiveNetIncome | -6,007,052 |
| 7 | BaseVar | 5,116,714 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -11.6 |
| 9 | EconomicCapitalRatio | 0.0000288 |
Edgar->Model Mapping
Feature Distribution
